These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 19846346

  • 1. High-dose-rate surface brachytherapy to boost elongated, curvilinear incisional scars after extrapleural pneumonectomy for malignant pleural mesothelioma treated with adjuvant intensity-modulated radiation therapy.
    Doyle LA, Showalter TN, Werner-Wasik M, Weksler B, Xiao Y, Yu Y, Macrone A, Liu H, Harrison A.
    Brachytherapy; 2010; 9(1):86-90. PubMed ID: 19846346
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.
    Miles EF, Larrier NA, Kelsey CR, Hubbs JL, Ma J, Yoo S, Marks LB.
    Int J Radiat Oncol Biol Phys; 2008 Jul 15; 71(4):1143-50. PubMed ID: 18262369
    [Abstract] [Full Text] [Related]

  • 4. Treatment planning system evaluation for mesothelioma IMRT.
    Stevens CW, Wong PF, Rice D, Jeter M, Forster K, Zhu XR.
    Lung Cancer; 2005 Jul 15; 49 Suppl 1():S75-81. PubMed ID: 15950806
    [Abstract] [Full Text] [Related]

  • 5. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
    Patel PR, Yoo S, Broadwater G, Marks LB, Miles EF, D'Amico TA, Harpole D, Kelsey CR.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):362-8. PubMed ID: 22516382
    [Abstract] [Full Text] [Related]

  • 6. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
    Allen AM, Czerminska M, Jänne PA, Sugarbaker DJ, Bueno R, Harris JR, Court L, Baldini EH.
    Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):640-5. PubMed ID: 16751058
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients.
    Aydogan B, Mundt AJ, Smith BD, Mell LK, Wang S, Sutton H, Roeske JC.
    Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):266-73. PubMed ID: 16618581
    [Abstract] [Full Text] [Related]

  • 12. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
    Hong L, Alektiar KM, Hunt M, Venkatraman E, Leibel SA.
    Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):752-9. PubMed ID: 15183478
    [Abstract] [Full Text] [Related]

  • 13. Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques.
    Hill-Kayser CE, Avery S, Mesina CF, James P, Friedberg JS, Cengel K, Lin LL, Hahn SM, Rengan R.
    J Thorac Oncol; 2009 Nov 01; 4(11):1431-7. PubMed ID: 19745767
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage.
    Duan J, Kim RY, Elassal S, Lin HY, Shen S.
    Int J Radiat Oncol Biol Phys; 2008 Jul 01; 71(3):765-71. PubMed ID: 18164832
    [Abstract] [Full Text] [Related]

  • 16. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: the Heidelberg experience.
    Münter MW, Thieke C, Nikoghosyan A, Nill S, Debus J.
    Lung Cancer; 2005 Jul 01; 49 Suppl 1():S83-6. PubMed ID: 15950807
    [Abstract] [Full Text] [Related]

  • 17. Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy.
    Gupta V, Krug LM, Laser B, Hudka K, Flores R, Rusch VW, Rosenzweig KE.
    J Thorac Oncol; 2009 Jun 01; 4(6):746-50. PubMed ID: 19404212
    [Abstract] [Full Text] [Related]

  • 18. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
    Rice DC, Smythe WR, Liao Z, Guerrero T, Chang JY, McAleer MF, Jeter MD, Correa A, Vaporciyan AA, Liu HH, Komaki R, Forster KM, Stevens CW.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):350-7. PubMed ID: 17467922
    [Abstract] [Full Text] [Related]

  • 19. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
    Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L, Bains MS, Downey RJ, Ginsberg RJ.
    J Thorac Cardiovasc Surg; 2001 Oct 01; 122(4):788-95. PubMed ID: 11581615
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.
    Guerrero M, Li XA, Ma L, Linder J, Deyoung C, Erickson B.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):933-9. PubMed ID: 15936580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.